Clinical Trials on Adult T-cell Leukemia-Lymphoma
Total 8184 results
-
Ruijin HospitalCompletedNasal Type Extranodal NK/T-Cell LymphomaChina
-
Cancer Institute and Hospital, Chinese Academy...CompletedStage I/II Extranodal NK/T-cell LymphomaChina
-
Samsung Medical CenterConsortium for Improving Survival of Lymphoma; Lymphoma Study Association; Deok-Hwan... and other collaboratorsCompletedExtranodal NK/T-cell Lymphoma, Nasal TypeKorea, Republic of
-
University of NebraskaNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Hepatosplenic T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-Negative | Stage II Angioimmunoblastic T-cell Lymphoma | Stage II Enteropathy-Associated T-Cell Lymphoma | Stage III Angioimmunoblastic... and other conditionsUnited States
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | B-Cell Non-Hodgkin Lymphomas(NHL)China
-
Shandong Provincial HospitalUnknownHepatosplenic T-cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | ALK-negative Anaplastic Large Cell Lymphoma | Angioimmunoblastic T Cell Lymphoma | Enteropathy Associated T Cell Lymphoma | Subcutaneous Panniculitis Like T Cell LymphomaChina
-
Ruijin HospitalUnknownALK-negative Anaplastic Large Cell Lymphoma | Peripherial T Cell Lymphoma,Not Otherwise Specified | Angioimmunoblastic T Cell Lymphoma | Enteropathy Associated T Cell Lymphoma | Hepatosplenic T Cell Lymphoma | Subcutaneous Panniculitis Like T Cell LymphomaChina
-
Northwestern UniversityNot yet recruitingCutaneous T Cell LymphomaUnited States
-
Fondazione Italiana Linfomi - ETSTerminatedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryItaly
-
Universitätsmedizin MannheimKlinikum Ludwigshafen; Wuerzburg University Hospital; KKS Netzwerk; Klinikum Minden and other collaboratorsCompletedCutaneous T Cell LymphomaGermany
-
Codiak BioSciencesTerminatedCutaneous T-cell Lymphoma (CTCL)United Kingdom
-
NYU Langone HealthLudwig Institute for Cancer ResearchTerminatedCutaneous T-cell LymphomaUnited States
-
University of AarhusAarhus University HospitalRecruitingPeripheral T-cell Lymphoma | NK/T-Cell LymphomaDenmark
-
Peking Union Medical College HospitalRecruitingCutaneous T-cell LymphomaChina
-
Peking Union Medical College HospitalPeking University Third Hospital; Dongzhimen Hospital, Beijing; Beijing Longfu...RecruitingCutaneous T-cell LymphomaChina
-
Northwestern UniversityRecruitingCutaneous T Cell LymphomaUnited States
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
Cyclacel Pharmaceuticals, Inc.TerminatedA Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)United States
-
Galderma R&DCompletedCutaneous T Cell LymphomaUnited States, France, Germany
-
Abramson Cancer Center of the University of PennsylvaniaCompletedCutaneous T Cell LymphomaUnited States
-
Far Eastern Memorial HospitalUnknownCutaneous T-cell LymphomaTaiwan
-
National Cancer Institute (NCI)CompletedLymphoma | Cutaneous | T-CellUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Adult... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States, Australia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedCutaneous T-cell Lymphoma | Peripheral T-cell LymphomaUnited States
-
Eisai Co., Ltd.CompletedCutaneous T-cell Lymphoma | Peripheral T-cell LymphomaJapan
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel
-
Jonsson Comprehensive Cancer CenterGilead SciencesTerminatedB-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Indolent Adult Non-Hodgkin Lymphoma | Absence of Signs or Symptoms | Digestive System Signs and Symptoms | Indolent Adult Non-Hodgkin LymphomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Boston Immune Technologies and TherapeuticsNot yet recruitingPeripheral T-cell Lymphoma | NHL | Cutaneous T Cell Lymphoma
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Adult Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMycosis Fungoides | Recurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Anaplastic Large Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Adult Acute Myeloid Leukemia...United States
-
University of PennsylvaniaChildren's Hospital of PhiladelphiaRecruiting
-
Royal Marsden NHS Foundation TrustCancer Research UKUnknownAngioimmunoblastic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Negative | Peripheral T-cell Lymphoma NOS | Hepatosplenic Gamma/ Delta T-cell LymphomaUnited Kingdom
-
Zhejiang UniversityShanghai First Song Therapeutics Co., LtdNot yet recruitingHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Gray Zone Lymphoma | NK/T Cell Lymphoma | Peripheral T Cell Lymphoma, Unspecified | Mediastinal B-Cell Diffuse Large Cell LymphomaChina
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLC; National Medical Research Council (NMRC), SingaporeNot yet recruitingRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaSingapore
-
CStone PharmaceuticalsNot yet recruitingExtranodal NK/T-cell Lymphoma
-
Memorial Sloan Kettering Cancer CenterRecruitingCutaneous T-cell LymphomaUnited States
-
Sun Yat-sen UniversityRecruiting
-
EQRx International, Inc.No longer availableExtranodal NK/T-cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingNon-Hodgkin Lymphoma | NK/T Cell Lymphoma | Vascular Immunomother T Cell LymphomaChina
-
Ruijin HospitalNot yet recruitingNK-T-Cell Lymphoma, ExtranodalChina
-
European Organisation for Research and Treatment...RecruitingStage IB-IIB Cutaneous T-Cell LymphomaSpain, United Kingdom, Denmark, Italy, France, Germany, Greece